BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

VaxInnate Corporation 

300 George Street
Suite 311
New Haven  Connecticut  06511  U.S.A.
Phone: 203-785-1421 Fax: 203-785-1461


SEARCH JOBS




Industry
Biotechnology






 Company News
VaxInnate Corporation Updates Plans To Advance Lead Vaccine Candidate, VAX2012Q In Elderly 10/8/2014 7:25:51 AM
Well-Capitalized VaxInnate Corporation Gets Another $6 Million For Its Bacteria-Based Flu Vaccines 10/3/2014 8:00:33 AM
VaxInnate Corporation Begins Phase I Clinical Trial To Evaluate Quadrivalent Vaccine For Prevention Of Seasonal Flu 3/19/2014 8:59:31 AM
VaxInnate Corporation Receives $2.1 Million From New Jersey’s Technology Business Tax Certificate Transfer Program 1/28/2014 9:40:49 AM
VaxInnate Corporation Awarded U.S. Government Grant to Develop Dengue Vaccine 4/4/2013 11:44:13 AM
VaxInnate Corporation’s License Agreement With Emergent BioSolutions (EBS) Improves U.S. Preparedness for Potential Flu Pandemics 1/16/2013 9:32:44 AM
Emergent BioSolutions (EBS) Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza Vaccine Candidate 1/2/2013 9:21:54 AM
Two New Executives Join VaxInnate Corporation Management Team 9/4/2012 10:12:13 AM
VaxInnate Corporation Begins Phase I Clinical Trial to Evaluate H5N1 Vaccine Candidate for Pandemic Avian Flu 6/12/2012 10:18:26 AM
VaxInnate Corporation Names Wayne Pisano as its New CEO 4/2/2012 10:18:39 AM
1234